Diagnostics at the frontline: using the Public Accounts Committee report to catalyse the UK’s antimicrobial resistance diagnostics strategy
The Lancet Microbe · 2026-01 · 7 (1) · 101243
DOI: 10.1016/j.lanmic.2025.101243 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Microbe, 2026-01. Verfasst von Seshasailam Venkateswaran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Precision Healthcare University Research Institute, Queen Mary University of London, London E11HH, UK. Electronic address: s.venkateswaran@qmul.ac.uk. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation, BBSRC.
Abstract (Originalsprache)
Between 2020 and 2024, the UK Government spent £567 million1 on its programme for tackling the growing threat of antimicrobial resistance (AMR), of which £543 million was allocated to the Department of Health and Social Care, National Health Service England, and UK Health Security Agency. On June 13, 2025, the UK Public Accounts Committee (PAC), which scrutinises government spending, published a review evaluating the effectiveness of this spending to address AMR risks through the measures set out in the national action plan (NAP).
Autor:innen und Institutionen
- Precision Healthcare University Research Institute, Queen Mary University of London, London E11HH, UK. Electronic address: s.venkateswaran@qmul.ac.uk.
- Global Agriculture and Food Systems, University of Edinburgh, Edinburgh, UK.
- Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; Paediatric Immunology and Infectious Diseases, Great North Children's Hospital, Newcastle upon Tyne, UK; National Institute f…
- Precision Healthcare University Research Institute, Queen Mary University of London, London E11HH, UK.
- NIAB, Cambridge, UK.
- UK Centre for Ecology and Hydrology, Wallingford OX108BB, UK. Electronic address: acsi@ceh.ac.uk.
Förderung
- UK Research and Innovation
- BBSRC
Zitieren
APA
Venkateswaran, S., Mitchell, J., Emonts, M., Bradley, M., Hawkins, N., & Singer, A. C. (2026). Diagnostics at the frontline: using the Public Accounts Committee report to catalyse the UK’s antimicrobial resistance diagnostics strategy. The Lancet Microbe, 7(1), 101243. https://doi.org/10.1016/j.lanmic.2025.101243
Vancouver
Venkateswaran S, Mitchell J, Emonts M, Bradley M, Hawkins N, Singer AC. Diagnostics at the frontline: using the Public Accounts Committee report to catalyse the UK’s antimicrobial resistance diagnostics strategy. The Lancet Microbe. 2026;7(1):101243. doi:10.1016/j.lanmic.2025.101243
BibTeX
@article{Venkateswaran2026,
author = {Venkateswaran, Seshasailam and Mitchell, Jessica and Emonts, Marieke and Bradley, Mark and Hawkins, Nichola and Singer, Andrew C},
title = {Diagnostics at the frontline: using the Public Accounts Committee report to catalyse the UK’s antimicrobial resistance diagnostics strategy},
journal = {The Lancet Microbe},
year = {2026},
volume = {7},
number = {1},
pages = {101243},
doi = {10.1016/j.lanmic.2025.101243}
}
EUVIMED